These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats. Kitano Y, Komiyama C, Makino M, Takasuna K, Takazawa A, Sakurada S. Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322 [Abstract] [Full Text] [Related]
3. Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate. Piredda SG, Woodhead JH, Swinyard EA. J Pharmacol Exp Ther; 1985 Mar; 232(3):741-5. PubMed ID: 3919174 [Abstract] [Full Text] [Related]
4. Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity. Giardina WJ, Dart MJ, Harris RR, Bitner RS, Radek RJ, Fox GB, Chemburkar SR, Marsh KC, Waring JF, Hui JY, Chen J, Curzon P, Grayson GK, Komater VA, Ku Y, Lockwood M, Miner HM, Nikkel AL, Pan JB, Pu YM, Wang L, Bennani Y, Durmuller N, Jolly R, Roux S, Sullivan JP, Decker MW. Epilepsia; 2005 Sep; 46(9):1349-61. PubMed ID: 16146429 [Abstract] [Full Text] [Related]
5. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E, Cloyd J, Critchley D, Fuseau E. Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [Abstract] [Full Text] [Related]
7. Anticonvulsant drug effects in the direct cortical ramp-stimulation model in rats: comparison with conventional seizure models. Krupp E, Löscher W. J Pharmacol Exp Ther; 1998 Jun; 285(3):1137-49. PubMed ID: 9618416 [Abstract] [Full Text] [Related]
8. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid. Shimshoni JA, Yagen B, Pessah N, Wlodarczyk B, Finnell RH, Bialer M. Epilepsia; 2008 Jul; 49(7):1202-12. PubMed ID: 18435754 [Abstract] [Full Text] [Related]
10. Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models. Blanco MM, dos Santos JG, Perez-Mendes P, Kohek SR, Cavarsan CF, Hummel M, Albuquerque C, Mello LE. Epilepsia; 2009 Apr; 50(4):824-31. PubMed ID: 19054404 [Abstract] [Full Text] [Related]
15. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Stöhr T, Kupferberg HJ, Stables JP, Choi D, Harris RH, Kohn H, Walton N, White HS. Epilepsy Res; 2007 May 28; 74(2-3):147-54. PubMed ID: 17433624 [Abstract] [Full Text] [Related]
16. Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures. Upton N, Blackburn TP, Campbell CA, Cooper D, Evans ML, Herdon HJ, King PD, Ray AM, Stean TO, Chan WN, Evans JM, Thompson M. Br J Pharmacol; 1997 Aug 28; 121(8):1679-86. PubMed ID: 9283703 [Abstract] [Full Text] [Related]
17. Additive anticonvulsant effect of flunarizine and sodium valproate on electroshock and chemoshock induced seizures in mice. Joseph S, David J, Joseph T. Indian J Physiol Pharmacol; 1998 Jul 28; 42(3):383-8. PubMed ID: 9741653 [Abstract] [Full Text] [Related]
18. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy. Bethmann K, Brandt C, Löscher W. Epilepsia; 2007 Apr 28; 48(4):816-26. PubMed ID: 17319923 [Abstract] [Full Text] [Related]
19. Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats. Swinyard EA, Sofia RD, Kupferberg HJ. Epilepsia; 1986 Apr 28; 27(1):27-34. PubMed ID: 3004930 [Abstract] [Full Text] [Related]